Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

Recruiting

VTDRestarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

Sponsor:

Boston Children's Hospital

Code:

NCT06683092

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

RETRIAL-Mental Health

RETRIAL-Liver

RETRIAL-Neuro

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2025-11-03.